Home / Asia Pacific / China approves use of GSK vaccine Cervarix for cervical cancer

China approves use of GSK vaccine Cervarix for cervical cancer

Drugmaker GlaxoSmithKline Plc said on Monday the China Food and Drug Administration (CFDA) has approved its human papillomavirus (HPV) vaccine, Cervarix, for use in the country to help women fight cervical cancer.
Source: Asia Pacific

About hmapj

Check Also

China denies its bomber aircraft on high state of alert amid North Korea tensions

China’s Defence Ministry on Friday denied reports that its bomber aircraft were on a heightened …

Leave a Reply

Your email address will not be published. Required fields are marked *